Company Profile · Healthcare

Encompass Health Corp

EHC · US
Exchange
US
Country
USA
IPO date
Sep 30, 1986
Employees
29,699
Current Price
$119.8
Live · Oct 4, 2026
Fair Buy
≤ $94
Margin-of-safety entry
Baillie Growth Score
37/100
Weak
Buffett Score
73/100
Strong
Intrinsic Value · Three-Tier Range Current price $119.8 Live · Within the fair intrinsic-value range

Composite valuation range · conservative $89–$94 / fair $115–$145 / optimistic $170–$185. At $119.8, Within the fair intrinsic-value range.

At publication $120.92 (Aug 25, 2026)

Market cap$11.82B
Revenue (TTM)$6.21B
EBITDA$1.46B
Profit margin10.01%
ROE24.97%
P/E (TTM)20
Forward P/E18.9
PEG0.41
EPS$5.99
Dividend yield0.64%
52-week range$92.25 – $127.28
Analyst target$148.17
Analyst rating4.9 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.